These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6105557)

  • 21. Community-initiated screening programme for beta-thalassaemia trait.
    Berdoukas VA; Webster BH; Raddatz B
    Med J Aust; 1983 Aug; 2(3):129-31. PubMed ID: 6877143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of a thai beta-thalassaemia heterozygote with normal haemoglobin A2 level: implication for population screening.
    Fucharoen S; Fucharoen G; Sanchaisuriya K; Pengjam Y
    Ann Clin Biochem; 2002 Jan; 39(Pt 1):44-9. PubMed ID: 11853188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Population intervention of thalassemia relying on family planning service system].
    FENG SW; GU JM; LI H; HUANG GT; ZHANG DM; CHEN GL; QU YX; TANG Y; JIANG F; Tang L; Wu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):223-6. PubMed ID: 21462141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A highly cost effective method of mass screening for thalassaemia.
    Silvestroni E; Bianco I
    Br Med J (Clin Res Ed); 1983 Mar; 286(6370):1007-9. PubMed ID: 6403170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening immediate family members for carrier identification and counseling: a cost-effective and practical approach.
    Ansari SH; Baig N; Shamsi TS; Saif-ur-Rehman ; Ansari ZH; Behar Z; Perveen K; Erum S; Bukhari ZR; Khan MT; Akbar M
    J Pak Med Assoc; 2012 Dec; 62(12):1314-7. PubMed ID: 23866481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of thalassaemia in Cyprus.
    Angastiniotis MA; Hadjiminas MG
    Lancet; 1981 Feb; 1(8216):369-71. PubMed ID: 6109998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An "on the spot" test for targeted screening in index families of thalassaemia.
    Yazdani MS; Ahmed S
    J Pak Med Assoc; 2010 Jul; 60(7):521-3. PubMed ID: 20578597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A strategy to detect beta-thalassaemia minor.
    Shine I; Lal S
    Lancet; 1977 Mar; 1(8013):692-4. PubMed ID: 66486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pros and cons of the fourth revision of thalassaemia screening programme in Iran.
    Moafi A; Vallian R; Vallian S; Rahgozar S; Torfenajad M; Moafi H
    J Med Screen; 2017 Mar; 24(1):1-5. PubMed ID: 26992783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified screening for alpha-thalassemia 1 (SEA type) using a combination of a modified osmotic fragility test and a direct PCR on whole blood cell lysates.
    Panyasai S; Sringam P; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Acta Haematol; 2002; 108(2):74-8. PubMed ID: 12187024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-thalassaemia in Cuba.
    de la Torre E; Hernandez P; Martinez G; Srarch E; Colombo B
    Haematologia (Budap); 1974; 8(1-4):71-9. PubMed ID: 4461439
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for thalassemia carriers in populations with a high rate of iron deficiency: revisiting the applicability of the Mentzer Index and the effect of iron deficiency on Hb A2 levels.
    Amid A; Haghi-Ashtiani B; Kirby-Allen M; Haghi-Ashtiani MT
    Hemoglobin; 2015; 39(2):141-3. PubMed ID: 25806419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait.
    Lipkin M; Fisher L; Rowley PT; Loader S; Iker HP
    Ann Intern Med; 1986 Jul; 105(1):115-23. PubMed ID: 3717782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NESTROFT as a screening test for the detection of thalassaemia & common haemoglobinopathies--an evaluation against a high performance liquid chromatographic method.
    Thomas S; Srivastava A; Jeyaseelan L; Dennison D; Chandy M
    Indian J Med Res; 1996 Aug; 104():194-7. PubMed ID: 8840659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of thalassemia: experiences from Samui Island.
    Sangkitporn S; Chongkitivitya N; Pathompanichratana S; Sangkitporn SK; Songkharm B; Watanapocha U; Pathtong W
    J Med Assoc Thai; 2004 Feb; 87(2):204-12. PubMed ID: 15061305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal control of severe thalassaemia: Chiang Mai strategy.
    Tongsong T; Wanapirak C; Sirivatanapa P; Sanguansermsri T; Sirichotiyakul S; Piyamongkol W; Chanprapaph P
    Prenat Diagn; 2000 Mar; 20(3):229-34. PubMed ID: 10719327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalassaemia as a model of recessive genetic disease in the community.
    Mouzouras M; Camba L; Ioannou P; Modell B; Constantinides P; Gale R
    Lancet; 1980 Sep; 2(8194):574-8. PubMed ID: 6106748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.
    Sangkitporn S; Sangkitporn S; Sangnoi A; Supangwiput O; Tanphaichitr VS
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1538-42. PubMed ID: 16610659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is haemoglobin G Philadelphia linked to -thalassaemia?
    French EA; Lehmann H
    Acta Haematol; 1971; 46(3):149-56. PubMed ID: 5001519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.